• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于耐氟喹诺酮类的非复杂性尿路感染,中药可能会有所帮助。

Fluoroquinolone-resistant uncomplicated urinary tract infections, Chinese herbal medicine may provide help.

作者信息

Tong Yanqing, Jing Yue, Zhao Dongkai, Zhang Liping, Zeng Shiming

机构信息

Department of Nephrology, The First Affilliated Hospital to Changchun University of Chinese Medicine, Changchun city, Jilin province, China.

出版信息

Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):108-14. doi: 10.4314/ajtcam.v8i5S.18. Epub 2011 Jul 3.

DOI:10.4314/ajtcam.v8i5S.18
PMID:22754063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3252729/
Abstract

We assessed the effects of Chinese herbs on the uncomplicated urinary tract infections (UTIs) in women caused by fluoroquinolone-resistant strains. A total of 56 pre-menopausal women with uncomplicated UTIs caused by fluoroquinolone-resistant strains were included. Urine cultures were carried out. All organisms were proved to be fluoroquinolone-resistant at baseline. The patients were orally administrated Chinese herbal concoction for ten days. Chinese herbal concoction eradicated the primary pathogen in 71.4% of the patients at the 1-week follow-up. Among the 20 patients who had bacteriologic failures in the Day 5 of treatment, 2 developed superinfection. Of the failures in the group, Proteus mirabilis, Staphylococcus epidermidis and Providencia rettgeri were implicated in 50.0%, 50.0% and 100.0% of the failures, respectively. The clinical outcomes were also good, with cure or improvement for more than 80% of all subjects. About 14% of the study subjects reported at least one potential adverse event. The adverse events most frequently reported were nausea and diarrhea. All patients tolerated the symptoms. The adverse reactions did not prevail after discontinuation of the medication. Chinese herbal therapy may be an acceptable alternative for the treatment of uncomplicated UTIs caused by fluoroquinolone-resistant uropathogens.

摘要

我们评估了中药对由耐氟喹诺酮菌株引起的女性单纯性尿路感染(UTIs)的疗效。共纳入56例由耐氟喹诺酮菌株引起单纯性UTIs的绝经前女性。进行了尿培养。所有微生物在基线时均被证明对氟喹诺酮耐药。患者口服中药煎剂10天。在1周随访时,中药煎剂使71.4%的患者根除了主要病原体。在治疗第5天细菌学治疗失败的20例患者中,2例发生了二重感染。在该组治疗失败的病例中,奇异变形杆菌、表皮葡萄球菌和雷氏普罗威登斯菌分别占失败病例的50.0%、50.0%和100.0%。临床结局也较好,超过80%的受试者治愈或病情改善。约14%的研究受试者报告至少发生过一次潜在不良事件。最常报告的不良事件是恶心和腹泻。所有患者均耐受这些症状。停药后不良反应未持续存在。中药疗法可能是治疗由耐氟喹诺酮尿路病原体引起的单纯性UTIs的一种可接受的替代方法。

相似文献

1
Fluoroquinolone-resistant uncomplicated urinary tract infections, Chinese herbal medicine may provide help.对于耐氟喹诺酮类的非复杂性尿路感染,中药可能会有所帮助。
Afr J Tradit Complement Altern Med. 2011;8(5 Suppl):108-14. doi: 10.4314/ajtcam.v8i5S.18. Epub 2011 Jul 3.
2
Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance.在抗菌药物耐药性不断增加的时代,单纯性尿路感染的治疗
Mayo Clin Proc. 2004 Aug;79(8):1048-53; quiz 1053-4. doi: 10.4065/79.8.1048.
3
Chinese herbal medicine: a safe alternative therapy for urinary tract infection in patients with renal insufficiency.中药:肾功能不全患者尿路感染的一种安全替代疗法。
Afr J Tradit Complement Altern Med. 2011 Dec 29;9(2):266-70. doi: 10.4314/ajtcam.v9i2.13. eCollection 2012.
4
Standardised Chinese herbal treatment delivered by GPs compared with individualised treatment administered by practitioners of Chinese herbal medicine for women with recurrent urinary tract infections (RUTI): study protocol for a randomised controlled trial.全科医生提供的标准化中草药治疗与中医师提供的个体化治疗对复发性尿路感染女性的疗效比较:一项随机对照试验的研究方案
Trials. 2016 Jul 27;17:358. doi: 10.1186/s13063-016-1471-5.
5
The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens.氟喹诺酮类药物在氟喹诺酮类耐药尿路病原体高发地区尿路感染管理中的作用。
Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1699-704. doi: 10.1007/s10096-011-1457-x. Epub 2011 Nov 4.
6
Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens.女性急性单纯性尿路感染的单剂量氟喹诺酮治疗:一项随机、双盲、多中心试验的结果,比较单剂量与3天氟喹诺酮治疗方案。
Urology. 2002 Mar;59(3):334-9. doi: 10.1016/s0090-4295(01)01562-x.
7
Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.日益增加的抗菌药物耐药性与非复杂性社区获得性尿路感染的管理
Ann Intern Med. 2001 Jul 3;135(1):41-50. doi: 10.7326/0003-4819-135-1-200107030-00012.
8
Risk factors for urinary tract infections due to ciprofloxacin-resistant Escherichia coli in a tertiary care urology department in Switzerland.瑞士一家三级护理泌尿科部门中,因环丙沙星耐药大肠埃希菌导致的尿路感染的危险因素。
Swiss Med Wkly. 2010 Jul 15;140:w13059. doi: 10.4414/smw.2010.13059. eCollection 2010.
9
Comparison of sparfloxacin and ciprofloxacin in the treatment of community-acquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group.司帕沙星与环丙沙星治疗女性社区获得性急性单纯性尿路感染的比较。司帕沙星多中心单纯性尿路感染研究组。
Clin Ther. 1999 Jun;21(6):966-81. doi: 10.1016/s0149-2918(99)80018-6.
10
Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.在决策和成本分析中,呋喃妥因作为经验性治疗单纯性尿路感染的推荐药物具有优势。
Mayo Clin Proc. 2011 Jun;86(6):480-8. doi: 10.4065/mcp.2010.0800. Epub 2011 May 16.

引用本文的文献

1
Low Concentration of Wenyang Tonglin Decoction Promotes Conjugation and Transfer of Drug-Resistant Plasmids among Heterologous Strains.低浓度温阳通淋汤促进耐药质粒在异源菌株间的接合与转移。
Chin J Integr Med. 2024 Aug;30(8):721-728. doi: 10.1007/s11655-024-3904-4. Epub 2024 May 31.
2
Functional immune boosters; the herb or its dead microbiome? Antigenic TLR4 agonist MAMPs found in 65 medicinal roots and algae's.功能性免疫增强剂;是草药还是其死亡的微生物群落?在65种药根和藻类中发现的抗原性Toll样受体4激动剂微生物相关分子模式
J Funct Foods. 2023 Aug;107. doi: 10.1016/j.jff.2023.105687. Epub 2023 Jul 29.
3
Prophylactic herbal therapy prevents experimental ascending urinary tract infection in mice.
Chin J Integr Med. 2016 Oct;22(10):774-7. doi: 10.1007/s11655-016-2601-3. Epub 2016 Jul 19.
4
Virulence genotype and phylogenetic groups in relation to Chinese herb resistance among Escherichia coli from patients with acute pyelonephritis.急性肾盂肾炎患者大肠埃希菌的毒力基因型、系统发育群与对中药的耐药性
Afr J Tradit Complement Altern Med. 2014 Apr 3;11(3):234-8. doi: 10.4314/ajtcam.v11i3.33. eCollection 2014.
5
Transfer of Herb-Resistance Plasmid From Escherichia coli to Staphylococcus aureus Residing in the Human Urinary Tract.抗草药物质粒从大肠杆菌向人尿道中的金黄色葡萄球菌的转移。
Jundishapur J Microbiol. 2014 Mar;7(3):e15056. doi: 10.5812/jjm.15056. Epub 2014 Mar 1.
6
Chinese herb-resistance and adherence to human uroepithelial cells of uropathogenic Escherichia coli.中国草药对尿路致病性大肠杆菌黏附及耐药性与人类尿道上皮细胞的影响
Afr J Tradit Complement Altern Med. 2013 Nov 2;11(1):109-15. doi: 10.4314/ajtcam.v11i1.16. eCollection 2014.
7
Chinese herbal medicine: a safe alternative therapy for urinary tract infection in patients with renal insufficiency.中药:肾功能不全患者尿路感染的一种安全替代疗法。
Afr J Tradit Complement Altern Med. 2011 Dec 29;9(2):266-70. doi: 10.4314/ajtcam.v9i2.13. eCollection 2012.

本文引用的文献

1
Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).门诊泌尿系统分离株中的抗生素耐药性:北美尿路感染协作联盟(NAUTICA)的最终结果。
Int J Antimicrob Agents. 2005 Nov;26(5):380-8. doi: 10.1016/j.ijantimicag.2005.08.003.
2
Longitudinal trends in antimicrobial susceptibilities across long-term-care facilities: emergence of fluoroquinolone resistance.长期护理机构中抗菌药物敏感性的纵向趋势:氟喹诺酮耐药性的出现
Infect Control Hosp Epidemiol. 2005 Jan;26(1):56-62. doi: 10.1086/502487.
3
Longitudinal trends in fluoroquinolone resistance among Enterobacteriaceae isolates from inpatients and outpatients, 1989-2000: differences in the emergence and epidemiology of resistance across organisms.1989 - 2000年住院患者和门诊患者肠杆菌科分离株中氟喹诺酮耐药性的纵向趋势:不同微生物耐药性出现情况及流行病学差异
Clin Infect Dis. 2004 Mar 1;38(5):655-62. doi: 10.1086/381549. Epub 2004 Feb 17.
4
Antimicrobial resistance trends and outbreak frequency in United States hospitals.美国医院的抗菌药物耐药性趋势及暴发频率
Clin Infect Dis. 2004 Jan 1;38(1):78-85. doi: 10.1086/380457. Epub 2003 Dec 8.
5
Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)?环丙沙星作为广谱经验性治疗药物——与β-内酰胺类药物相比,氟喹诺酮类药物仍是可行的单一治疗药物吗:来自MYSTIC项目(美国)的数据?
Diagn Microbiol Infect Dis. 2002 Mar;42(3):213-5. doi: 10.1016/s0732-8893(01)00343-1.
6
Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan.密歇根州尿路致病性大肠杆菌分离株中甲氧苄啶-磺胺甲恶唑耐药性的流行情况及预测因素
Clin Infect Dis. 2002 Apr 15;34(8):1061-6. doi: 10.1086/339491. Epub 2002 Mar 11.
7
Management of uncomplicated urinary tract infections.单纯性尿路感染的管理
West J Med. 2002 Jan;176(1):51-5. doi: 10.1136/ewjm.176.1.51.
8
National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.门诊医生对女性尿路感染的治疗的全国模式。
Arch Intern Med. 2002 Jan 14;162(1):41-7. doi: 10.1001/archinte.162.1.41.
9
Emerging mechanisms of fluoroquinolone resistance.氟喹诺酮耐药性的新出现机制
Emerg Infect Dis. 2001 Mar-Apr;7(2):337-41. doi: 10.3201/eid0702.010239.
10
Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.金黄色葡萄球菌、特定肠杆菌科细菌及铜绿假单胞菌在体外单次及多次暴露于环丙沙星、左氧氟沙星和曲伐沙星后的表型耐药性。
Antimicrob Agents Chemother. 2001 Mar;45(3):883-92. doi: 10.1128/AAC.45.3.883-892.2001.